|
|
News for Healthier Living
First Patient Treated with Federally Approved Lyfgenia(tm) for the Curative Gene Therapy Treatment of Sickle Cell Disease Leaves Joseph M. Sanzari Children's Hospital at Hackensack University Medical
The completion of the patient's treatment for sickle cell is the second pediatric curative gene therapy treatment completed this year on the Hackensack University Medical Center campus. The Lyfgenia treatment comes on the heels of Joseph M. Sanzari's treatment of a young girl who underwent treatment for another inherited blood disorder. The patient was treated with beta thalassemia using Zynteglo, which was approved by the FDA for the treatment of the inherited blood disorder at the same time as Lyfgenia was approved for sickle cell.
June 6, 2025
June 7 2025June 6 2025June 5 2025June 4 2025June 3 2025June 2 2025June 1 2025May 31 2025May 30 2025May 29 2025May 28 2025 - World No Tobacco Day 2025: Unmasking Big Tobacco's Youth Marketing Playbook
- Scientists Find Promise in a New Peptide Drug to Combat a Deadly Brain Cancer
- The Medical Minute: The ABCs of Diabetes
- Helping Kids Have a Safe Summer: 12 Tips from Johns Hopkins Pediatricians
- How to Help Teen Drivers Stay Safe on the Road
- Mayo Clinic Experts Present Key Cancer Research Findings at ASCO
- Wildfire Pollution May Lower Survival Chances for Lung Cancer Patients
- Rural Georgians Lack Access to Alzheimer's Disease Treatment
- AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery
- Understanding Brain Tumors: What You Need to Know
- Having Your Child's Tonsils and Adenoids Out May Help with Snoring, Mouth Breathing
- Will This Year's Flu Shot Protect You? The Answer Is Hidden in Your Blood
- John Theurer Cancer Center Presents Innovative Cancer Research at Major Annual Cancer Meeting, Offering New Hope for Patients
- Understanding How a Rare Brain Wasting Disease Hides in Neurons For Decades
- T Cells Take Up Residence in the Healthy Brain Via a Gut-Fat-Brain Axis
- Immune Checkpoint Inhibitors 'High-Risk Yet Promising' for Cancer Patients Who Undergo Organ Transplant
- Singing to Babies Improves Their Moods
- Kahlert Institute for Addiction Medicine Finds Innovative Approaches to Fighting Fourth Wave of Opioid Public Health Crisis
- Research Project Studies High Doses of an Opioid Abuse Disorder Medication Among Veterans
- Why the FDA Recalled Six Popular Acne Products
- Yale Scientists Uncover Sex Differences in Recalling and Reporting of Family History of Alzheimer's Disease
- Medical Cannabis Reduces Pain, Preserves Cognition, Study Reveals
- After Mild Stroke, More Sleep or Time Spent Trying to Sleep Tied to Thinking Problems
- Shedding Pounds in Middle Age Could Add Years to Your Life, Study Finds
- RFK Jr. Ends COVID Vaccine Urging for Healthy Kids, Pregnant Women
- Miley Cyrus Reveals Rare Condition That Shapes Her Signature Voice
- Paracetamol to Poisoning: When Medicines Harm Instead of Heal
- Mother's Warmth in Childhood Influences Teen Health by Shaping Perceptions of Social Safety
- Standardized Huddle Process Improves Response to Unprofessional Behaviors in Health Care Settings
- One in Three Youth with Mental Health Crisis Spent Over 12 Hours in Emergency Department Waiting for Psychiatric Bed
- Vascular Sleuth Unlocks Origins of Congenital Limb Deficiencies--Beyond Thalidomide
- EQUAL Study Launches Lung Cancer Screening Trial for People at High Risk
- Helmets Save Lives, Head-To-Head Motorcycle Study Finds
- New Electrode Design Might Help Spasms, Pain, Paralysis
- AI Helps ID Candidates For Targeted Breast Cancer Treatment
- Preschool BMI Can Predict Childhood Obesity Risk
- Climate Change Could Be Fueling Female Cancer Deaths
- Weight-Loss Drugs May Lower Risk Of Obesity-Related Cancers
- Cardiorespiratory Effects of Wildfire Smoke Particles Can Persist for Months, Even After a Fire Has Ended
May 27 2025May 26 2025May 25 2025May 24 2025
|
|
|
|
|